First-of-its-kind agreement between Amgen and a standalone PBM Miami, FL – Abarca, a pharmacy benefit manager (PBM) disrupting the industry with smarter technology and innovative strategies, today announced it has signed an outcomes-based contract with Amgen for the cholesterol-lowering drug, Repatha® (evolocumab). This agreement is the first of its kind involving Amgen’s Repatha and a